Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Bioident

Agilent Technologies this week launched its Human 244K CpG Island Microarrays for studying epigenetics.
Specifically, the arrays can be used for studying DNA methylation changes that can be correlated to cancer formation, organism development, genomic imprinting, gene silencing, and chromatin stability, Agilent said.
The company added that it plans to add other organisms to its CpG array line in coming months. 

Bioident, a subsidiary of Nanoident, this week launched its PhotonicLab Platform, a disposable lab-on-a-chip system that the firm claims can enable mobile, real-time and multi-parameter detection of chemical and biological substances.
According to Wasiq Bokhari, Bioident’s CEO, PhotonicLab uses a 900-site microfluidics array, as well as a hand-held detector that can wirelessly transfer the data from the chip to a PC or laptop.
Bokhair told BioArray News last week that the company is looking to partner with other companies to co-develop and market applications for water analytics, multi-analyte detection, and multiplexed molecular diagnostic assays as possible applications based on the PhotoLab Platform.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.